Mastercard Incorporated (MA) gains 2% Over Preliminary Judicial Approval of $38 billion Swipe-Fee Settlement

Insider Trading
Mastercard shares rose about 2% after a judge preliminarily approved a $38 billion swipe‑fee settlement with Visa.

Summary

On June 9, a U.S. federal judge gave preliminary approval to a revised $38 billion settlement between Visa, Mastercard and merchants over alleged excessive swipe fees. The settlement, which resolves litigation dating back to 2005, includes a 0.1% reduction in swipe fees for five years and caps standard consumer rates at 1.25% for eight years, while giving merchants more flexibility to impose surcharges and choose which card types to accept. Judge Brian Cogan noted that although many objections had merit, the deal represents the best achievable outcome given trial risks. Mastercard’s stock rose roughly 2% on the news. The article also notes the company’s headquarters in New York and briefly mentions the author’s view that AI stocks may offer higher returns.

(Source:Insider Trading)

New York Post

Costco class action lawsuit settlement could earn affected customers $500

The Philadelphia Inquirer

A property manager used rent price-setting algorithms that were banned in Philly last year, lawsuit says

Bloomberg Tax News

Union Sues EEOC Over Suspended Federal Worker Class Actions (1)

The Economic Times

How Oracle's 2012 court defeat became the heart of £270 million lawsuit against Microsoft

7NEWS Australia

Johnson & Johnson to pay $7.9 billion in landmark talc cancer settlement as Australian class action gathers pace

Natural News

Federal Judge Approves $1.5 Billion Copyright Settlement Against AI Company Anthropic

San Diego Union-Tribune

San Diego appeals court finds that license plate data collection alone is not harm

Charleston Post and Courier

Richland County to settle class-action case over inadequate care brought by mentally ill detainees

City A.M.

Trawlerman can overhaul Scandinavia for Goodwood gold

Electrek

Tesla partly settles racism lawsuit as hundreds of workers press on

Mint

UPI-linked PF claim settlement facility rollout delayed: Expected launch timeline and key benefits for EPFO members

Bnn Bloomberg

Canadians may be eligible for a piece of this class-action involving a drug used to treat depression, schizophrenia

CP24 Toronto

Canadians may be eligible for a piece of this class-action involving a drug used to treat depression, schizophrenia

The Globe and Mail

Deadline nears to file claim in class-action lawsuit over drug Rexulti

BayToday

Deadline fast approaching for Canadians to file claim in class-action drug suit